Resumen: Glioblastoma (GBM) is a highly malignant brain tumour characterised by limited treatment options and poor prognosis. The tumour microenvironment, particularly the central hypoxic region of the tumour, is known to play a pivotal role in GBM progression. Cells within this region adapt to hypoxia by stabilising transcription factor HIF1-α, which promotes cell proliferation, dedifferentiation and chemoresistance. In this study we sought to examine the effects of NNC-55-0396, a tetralol compound which overactivates the unfolded protein response inducing apoptosis, using the organ-on-chip technology. We identified an increased sensitivity of the hypoxic core of the chip to NNC, which correlates with decreasing levels of HIF1-α in vitro. Moreover, NNC blocks the macroautophagic process that is unleashed by hypoxia as revealed by increased levels of autophagosomal constituent LC3-II and autophagy chaperone p62/SQSTM1. The specific effects of NNC in the hypoxic microenvironment unveil additional anti-cancer abilities of this compound and further support investigations on its use in combined therapies against GBM. Idioma: Inglés DOI: 10.1038/s41419-024-06492-1 Año: 2024 Publicado en: CELL DEATH & DISEASE 15, 2 (2024), 127 [8 pp.] ISSN: 2041-4889 Factor impacto JCR: 9.6 (2024) Categ. JCR: CELL BIOLOGY rank: 29 / 204 = 0.142 (2024) - Q1 - T1 Factor impacto SCIMAGO: 2.773 - Cancer Research (Q1) - Cell Biology (Q1) - Medicine (miscellaneous) (Q1) - Immunology (Q1) - Cellular and Molecular Neuroscience (Q1)